Evidence map›Paper›PMID 12190118›Full record

ArticleMolecular and cellular biochemistry2002

Characterization of the in vitro kinase activity of a partially purified soluble GST/JAK2 fusion protein.

Roy J Duhé, Emily A Clark, William L Farrar

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Roy J DuhéIntramural Research Support Program, SAIC-Frederick, MD, USA. RDUHE@pharmacology.umsmed.edu
Emily A Clark
William L Farrar
Frederick National Laboratory for Cancer Research · USNational Cancer Institute · USScience Applications International Corporation (United States) · US

Funding

NCI NIH HHS N01-CO-5600
6 · The paper itself

Abstract

The biochemical and biophysical characteristics of Janus protein-tyrosine kinases (JAKs), which are essential early mediators of cytokine-initiated signal propagation, are virtually undefined. To facilitate the in vitro analysis of JAK-mediated catalysis, we substantially purified a soluble recombinant JAK2 and developed a novel means of quantifying JAK-catalyzed product formation. Glutathione-S-transferase fusion proteins containing active and inactive forms of rat Janus kinase 2 (GST:rJAK2 and GST:rJAK2(CA795)) were highly purified via affinity chromatography. A microtiterplate-based ELISA was used to measure tyrosine phosphorylation of a streptavidin-immobilized biotinylated STAT1-derived peptide. The ELISA data indicated that only about 1% of the enzyme was involved in exogenous substrate phosphorylation. Other immobilized peptides served as apparent substrates with varying efficacy. Traditional radioisotopic autokinase assays demonstrated that the activity of the purified fusion protein was inhibited by a variety of tyrphostin inhibitors. Non-radiolabeled adenine nucleotides, but not guanine nucleotides, inhibited the radioisotopic autokinase assay. These observations verify that the catalytic activity of JAK2 is highly regulated, and are consistent with the suggestion that JAK2 may require additional accessory proteins, such as a potential upstream regulatory kinase, for full catalytic activity.

Indexed as

Proto-Oncogene ProteinsAdenineAnimalsBiotinylationCatalysisCell LineChromatography, AffinityDNA-Binding ProteinsDNA, ComplementaryDose-Response Relationship, DrugElectrophoresis, Polyacrylamide GelEnzyme InhibitorsEnzyme-Linked Immunosorbent AssayGlutathione TransferaseGuanineInsectaAdenineDNA-Binding ProteinsDNA, ComplementaryEnzyme InhibitorsGlutathione TransferaseGuanineJak2 protein, ratJanus Kinase 2PeptidesProtein-Tyrosine KinasesProto-Oncogene ProteinsRecombinant Fusion ProteinsStat1 protein, ratSTAT1 Transcription FactorTrans-ActivatorsTyrosineTyrphostins

Identifiers

PMID12190118
OpenAlexW192689048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.